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Abstract
Acute kidney injury following cardiac surgery (AKICS) remains a frequent cause of major morbidity and mortality. The aim of this study
was to examine the influence of timing of dialysis. A retrospective analysis of 3528 patients undergoing cardiac surgery between April 1995
and July 2006 was performed. In group 1 (April 1995–January 2000) intermittent haemodialysis was resorted to when other supportive
measures failed. In group 2 (January 2000–July 2006) intermittent haemodialysis was commenced immediately when oliguria did not
respond to fluid replacement or single-dose diuretics. In group 1, 49y1511 (3.2%) patients developed AKICS. Thirty-four patients did not
receive dialysis and six patients died (18%). Of the remaining 15 patients who underwent dialysis, 13 died (87%). The overall mortality for
group 1 AKICS patients was 19y49 (39%). In group 2, 87y2017 (4.3%) patients developed AKICS. Thirty-one patients did not require dialysis
and none died. Of the 56 patients who were dialysed, 14 died (25%). During January 2005–July 2006, mortality following dialysis fell
further to 17% (4y24). The overall mortality for group 2 patients developing AKICS was 14y87 (16%). Although the incidence of AKICS
increased from 3.2% to 4.2%, earlier dialysis resulted in significantly improved survival (Ps0.00001).
! 2008 Published by European Association for Cardio-Thoracic Surgery. All rights reserved.
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1. Introduction
Acute kidney injury is a serious complication after cardiac
surgery. It is well recognised that patients who develop
acute kidney injury following cardiac surgery (AKICS) have
a high mortality rate, both perioperatively and in the
medium term w1, 2x. The term acute renal injury includes
a broad range of definitions. Hence, the varying incidences
reported after cardiac surgery, from as low as 1% w3x to as
high as 7% w4x. Arbitrary values for acute renal injury have
been used in various studies, such as a serum creatinine
exceeding 200 mmolyl or a rise of 50 mmolyl over a base-
line of 175 mmolyl w5x. Severe acute renal injury has been
defined as a serum creatinine exceeding 500 mmolyl or a
clinical situation requiring renal replacement therapy w6x.
This last definition is of course open to the widest inter-
pretation but is, perhaps, the most relevant when it comes
to clinical practice. The definition of AKICS in this study
was oliguria andyor the need for renal replacement therapy.
In those patients undergoing renal replacement therapy
the mortality has been variously reported in the range of
22–67% w2, 4x. Interestingly, a high mortality has been
reported both in studies prior to 2000, as in the study from
the Brigham and Women’s Hospital, Boston, Massachusetts,
quoting a mortality of 63.7% w1x as well as in recent studies,
such as the one from San Raffaele Hospital, Milan published
in 2006, quoting a mortality of 66.7% w7x. However, a study
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from Leicester w8x reported in 2004 showed that early renal
replacement therapy during the first day post surgery, this
time with continuous veno-venous haemofiltration,
achieved a significantly lower mortality of 22% when com-
pared with the same treatment started two and a half days
after surgery when the mortality was 43%. Other studies,
using early veno-venous haemofiltration w9x or early veno-
venous haemodiafiltration w10x have corroborated these
findings. Although these different studies cannot be com-
pared because they used different criteria for defining
acute renal injury and for instituting renal replacement
therapy, the studies comparing early with late renal
replacement therapy within the same population draw a
very valid conclusion.
2. Materials and methods
We retrospectively analysed 71 patients who were dia-
lysed after cardiac surgery, from a single surgeon’s prac-
tice, spanning an 11-year period from April 1995 to July
2006. Data were obtained from the patients’ files as well
as from our cardiac surgery database. Data regarding the
timing and number of dialysis sessions were cross-refer-
enced with our renal unit.
We divided the population under study into two groups:
group 1, from April 1995 to January 2000, comprised 15
patients and group 2, from January 2000 up to July 2006,
comprised 56 patients. The two groups reflect our policy
change with regard to the treatment of acute renal injury
after cardiac surgery.
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Table 1
Demographics, biochemical parameters, timing and number of sessions of dialysis, and mortality in groups 1 and 2
Group 1 Group 2 P-value
t-test x -test2
Age (years) 63.7"10.9 66"9.1 0.49 –
Diabetes 47% 47% – 0.92
Hypertension 60% 63% – 0.76
Prostatism 13% 9% – 0.61
ACE inhibitors 27% 31% – 0.78
Enalapril 20% 11% – 0.34
Perindopril 7% 20% – 0.23
Pre-op creatinine (mmolyl) 111.6"57.0 118.1"42.2 0.69 –
Pre-op urea (mmolyl) 8.5"3.8 10.0"3.6 0.20 –
Creatinine )100 mmolyl 40% 55% – 0.20
Urea )10 mmolyl 33% 40% – 1.0
Predialysis creatinine (mmolyl) 403.7"183.5 233.9"73.7 0.003* –
Predialysis urea (mmolyl) 35.2"17.7 14.4"3.1 0.004* –
Predialysis K (mmolyl)q 5.3"0.8 4.9"0.5 0.13 –
Predialysis pH 7.256"0.08 7.353"0.06 0.0004* –
Surgery to dialysis (h) 139.1"137.1 41.6"36.2 0.015* –
Oliguria to dialysis (h) 41.2"22.8 8.6"8.2 0.000064* –
Number of dialysis 6.5 1.8"0.9 0.684 –
sessions in survivors
Survival 13% 75% – 0.0000125*
*Denotes statistical significance.
We obtained the following data: the patient’s age, history
of diabetes, hypertension, prostatism, and use of ACE
inhibitors, the preoperative baseline creatinine and urea,
the percentage of patients with raised creatinine and urea
as well as the peak values before dialysis was started; the
potassium and pH values immediately before dialysis; the
time lapse from surgery to dialysis and from the onset of
oliguria (-0.5 mlykgyh) to dialysis, and the number of
sessions of dialysis administered. These values are recorded
in Table 1. Statistical significance was accepted at a level
of P-0.05.
Our policy with regard to treatment of renal injury
changed with our understanding of this complex clinical
problem. Initially, renal support measures were instituted
and utilised to the full, only reserving renal replacement
therapy as a last resort when it became impossible to
correct hyperkalaemia. This policy was based on our unto-
ward early experience with dialysis and the high mortality
related to this treatment modality in our unit. It later
became apparent that our poor results may have resulted
from the late institution of dialysis, and we therefore
embarked on a programme of early dialysis to test this
hypothesis.
The renal support measures were employed when oliguria,
defined as -0.5 mlykgymin urine output, set in. These
included fluid replacement when the central venous pres-
sure permitted, intravenous loop diuretics, in single doses
followed by infusion, osmotic diuretics, low dose dopamine
as a diuretic, other inotropes as indicated by the clinical
condition, dextrose-insulin infusion and enteral calcium
resonium, in varying combinations. In group 2, dialysis was
commenced immediately when oliguria occurred and did
not respond to fluid replacement and single dose intrave-
nous diuretics (limited renal support measures). In two
cases renal replacement therapy was required for correc-
tion of hyperkalaemia in the absence of oliguria.
3. Results
During the study period from April 1995–July 2006, 71 out
of 3528 (2.01%) cardiac surgery patients were treated with
dialysis postoperatively: 15y1511 (0.99%) patients in group
1 from April 1995 to January 2000 and 56y2017 (2.78%)
patients in group 2 from January 2000 to July 2006. Full
renal support measures were instituted in 34y1511 (2.25%)
in group 1 and limited renal support measures in 31y2017
(1.54%) in group 2. Thus, the use of renal support measures
declined in favour of an increase in the use of dialysis (Fig.
1).
3.1. Demographics
Groups 1 and 2 did not differ significantly in age distri-
bution, incidence if diabetes, hypertension or prostatism.
The preoperative use of ACE inhibitors was not statistically
different in the two groups, with a trend away from
enalapril in favour of perindopril.
3.2. Biochemical parameters
The mean preoperative creatinine and urea as well as the
percentages of patients with raised preoperative values
were not significantly different.
The pre-dialysis creatinine was significantly lower in group
2 (403.7"183.5 mmolyl vs. 233.9"73.7 mmolyl, Ps0.003)
as was the pre-dialysis urea (35.2"17.7 vs. 14.4"3.1
mmolyl, Ps0.004) as a result of the institution of early
dialysis. The pre-dialysis potassium was similar in the two
groups. Early dialysis prevented the development of meta-
bolic acidosis.
3.3. Timing and number of sessions of dialysis
The time lapse from surgery to dialysis was significantly
reduced in group 2 (from 139.1"137.1 h to 41.6"36.2 h,
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Fig. 1. Management of acute kidney injury, showing number of patients treat-
ed per year in this study with differing renal support.
Ps0.015) as was the period from the onset of oliguria to
dialysis (from 41.2"22.8 h to 8.6"8.2 h, Ps0.000064). In
group 1 the two dialysis survivors required 7 and 6 sessions,
respectively, before recovery. In group 2 the 42 dialysis
survivors required a mean of 1.8"0.9 dialysis sessions
before recovery.
3.4. Mortality after dialysis
In group 1, prior to January 2000, 13 of the 15 patients
who received dialysis after cardiac surgery died peri-oper-
atively, giving a mortality of 87%. In group 2, from January
2000 until July 2006, 14 out of 56 patients died after
receiving dialysis, giving a mortality of 25%. If we look at
our results from the last two years of the study, only 4 out
of 24 patients who received dialysis died peri-operatively,
and so the mortality has recently dropped further to 17%.
There has been a significant and steady reduction in mor-
tality as we have pursued our policy of early dialysis.
4. Discussion
Our management of acute renal injury after cardiac
surgery has evolved over the study period. A policy decision
was taken in January 2000 to perform early dialysis in an
attempt to decrease the high mortality that was prevalent
up to that time. This has resulted in an almost three-fold
rise (0.99–2.78%) in the use of dialysis. During this same
period our combined mortality (following renal supportive
measures and dialysis) fell from 39% to 16%, a 2.4-fold
reduction. In the latter part of the study, from January
2005 to July 2006 (ns445), the combined mortality follow-
ing limited renal support measures only (administered in
12 patients) and early dialysis (administered in 24 patients)
was 11% (4y36), representing a 3.5-fold reduction. This
policy has encouraged us to accept patients for surgery
who would otherwise have been refused in the past because
of impaired renal function. Dialysis is now started as soon
as oliguria ceases to respond to limited renal support
measures. A double lumen catheter is inserted in the
femoral vein using local anaesthetic and a 4 h dialysis
session performed via this route. The commonest time for
this to happen is during the first and second postoperative
days (median 32 h). Additional support measures at this
stage such as increasing inotropic support, further diuretic
treatment or a dextrose insulin infusion are unlikely to
result in renal recovery. Our results demonstrate that
although full renal support measures may correct the serum
potassium levels to a degree (5.3"08. vs. 4.9"0.5 mmolyl,
Ps0.13), patients in group 1 were significantly acidotic, a
situation avoided in group 2 (pH 7.256"0.08 vs.
7.353"0.06, Ps0.0004). The consequent delay in dialysis
which resulted from this policy as practised in group 1
resulted in a high mortality.
When dialysis is administered in the first 24 h post-
operatively it is our policy to avoid a net removal of fluid.
After this time a 2 l reduction is normally well tolerated.
We do not fully anti-coagulate the patient with heparin but
infuse a dose of 5000 U into the dialysis circuit. We
invariably dialyse against a potassium concentration of
1 mmolyl. The occurrence of atrial fibrillation is not
uncommon and we have also observed this event to herald
the early resumption of a diuresis. Renal recovery occurs
early following this strategy, with a mean of 1.8"0.9
dialysis sessions in group 2 survivors. One may argue that
we are perhaps instituting dialysis in patients who may not
require it and may go on to recover spontaneously. In
patients who are still passing urine in adequate quantity, a
rising creatinine is not, in itself, an indication for renal
replacement therapy. However, when the patient becomes
oliguric, anuric or hyperkalaemic in spite of a normal
diuresis there is no advantage in delaying renal replace-
ment therapy. Our experience from group 1 patients prior
to January 2000 clearly demonstrates the dangers of delay.
Our policy of early dialysis has also widened our scope for
revascularisation in patients with preoperative renal
impairment in whom surgery would, in many cases, have
been denied prior to January 2000.
When acute kidney injury presented as part of multi-organ
failure, our experience with dialysis was uniformly unsuc-
cessful. This clinical picture always included cardiogenic or
septic shock, singly or in combination. Multi-organ failure
was the cause of death of 9 of the 13 deaths in group 1
and in 9 of the 14 deaths in group 2. The incidence of this
condition and the poor outcome has remained unchanged
over the study period and early dialysis in this situation has
not improved our results. Furthermore, our results do not
support the notion that early dialysis may prevent the
progression from isolated kidney injury to multi-organ fail-
ure. Although the use of early dialysis has increased three-
fold, the mortality from dialysis in the setting of
multi-organ failure has remained unchanged. In a recent
paper by Tillyard et al. w5x the authors concluded that
acute kidney injury in intensive care is a mongrel and not
a pedigree diagnosis and serves only to identify when
another organ has failed. Acute kidney injury as a single
system failure is a distinct entity and carries a vastly
different prognosis from that of acute kidney injury as part
of a syndrome of multi-organ failure.
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The jury is still out on which renal replacement therapy
is the most appropriate w11, 12x. We have gained experience
with haemodialysis having encountered early coagulation
problems with the use of continuous veno-venous dialysis.
Clearly each unit will utilise the method which they have
gained more experience with and which best suits their
needs. Our results are comparable with those obtained with
continuous veno-venous dialysis.
Whereas ten years ago the onset of postoperative acute
kidney ushered a sense of doom, our experience with early
dialysis has changed this outlook and renal replacement
therapy has become simply another modality of postoper-
ative care in the cardiac patient.
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